SRNE Chart
- 52-Week Range: $0.00 - $0.16
- Market Capitalization: $0.99M
- Short Percentage: 11.96%
- Target Price: $13.00
- Shares Outstanding: 551.28M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
SRNE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
Latest Stock News
- Stocks, Bonds, Dollar Barely Budge After JOLTS: Markets Wrap | Yahoo FinanceDec 3, 10:18am
- European markets trade higher; French stocks hold onto gains despite political upheaval | CNBCDec 3, 10:12am
- Why Super Micro Computer Stock Jumped in November and Could Soar Even Higher | Yahoo FinanceDec 3, 10:10am
- Stock market today: S&P 500, Nasdaq drift near record levels as Dow falls following key jobs data | Yahoo FinanceDec 3, 10:10am
- South Korean Stocks Tumble, Won Drops as Martial Law Declared | Yahoo FinanceDec 3, 10:02am
- South Korean Stocks Tumble, Won Drops as Martial Law Declared | BloombergDec 3, 10:02am
- Stock market today: Indexes slip after hitting records as investors await fresh economic data | Markets InsiderDec 3, 09:54am
- What's Going On With Palantir Technologies Stock Today? | Yahoo FinanceDec 3, 09:45am
- Is Tesla Stock A Buy Or A Sell After Delaware Judge Rejects Elon Musk's Pay Deal? | Investor's Business DailyDec 3, 09:45am
- What's Going On With Palantir Technologies Stock Today? | BenzingaDec 3, 09:45am
Company Info
Website: https://www.sorrentotherapeutics.com
Address: 4955 Directors Place, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 949
Address: 4955 Directors Place, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 949
$SRNE gonna take my L with this one
$SRNE come to papa
$SRNE Exciting times ahead people.
$SRNE money comes and goes but your story stays with you the rest of your life. Apes for life ??
$SRNE hi hi
$SRNE wow. The volume is so low today. Unreal
$SRNE Yolo
$SRNE we need to get moving
$SRNE take what we can get
$SRNE one of the poorest performed stocks for a big name.